• Thoracic Surgery
• University of Texas MD Anderson Center - Thoracic Surgical Oncology
• UCLA School of Medicine - Surgical Oncology
• UCLA School of Medicine - Medical Scientist Fellow Program
• Texas Heart Institute - Cardiothoracic Surgery
• University of California, Irvine Medical Center - General Surgery
• UCLA School of Medicine - MD
Dr. Toloza, born in the Philippines and raised in southern California, received his undergraduate degree in 1984 at the University of California, Los Angeles (UCLA). He also received both his medical degree and a Ph.D. from UCLA. In 1991, he completed his internship and residency in General Surgery at the University of California, Irvine Medical Center, during which time he also completed a Surgical Oncology Research Fellowship at UCLA, where he performed gen therapy research for melanoma and sarcoma. He completed his Cardiothoracic Surgery residency in 2000 at the Texas Heart Institute in Houston, TX, where he also completed a concurrent Thoracic Surgical Oncology Fellowship at the University of Texas M.D. Anderson Cancer Center.
A Diplomat of the American Board of Surgery, the American Board of Thoracic Surgery, Dr. Toloza began his practice in 2000 as a Cardiothoracic Surgeon at the Duke University Medical Center in Durham, NC, where he was an Assistant Professor of Surgery. In 2010, Dr. Toloza came to the H. Lee Moffitt Cancer Center in Tampa, FL, where he practices full-time as a Thoracic Oncologist and is an Associate Member in the multi-disciplinary Thoracic Oncology Program. He also has a concurrent appointment as Associate Professor of Surgery and Associate Professor of Oncologic Sciences in the University of South Florida College of Medicine in Tampa.
Dr. Toloza is involve in several lung cancer clinical research programs and has authored or co-authored numerous medical journal articles, book chapters, and books. He is involved in the evaluation and aggressive combined-modality treatment of all stages of lung cancer and mesothelioma, as well as in the evaluation and treatment of mediastinal and chest wall masses and also pulmonary metastases from a variety of primary extrathoracic malignancies. He is also one of only a few thoracic surgeons worldwide who is certified to perform robotic-assisted thoracic surgery for primary lung cancer, pulmonary metastases, and mediastinal masses.